Cross-Site Scripting Vulnerability in IBM Engineering Products
CVE-2021-20350

5.4MEDIUM

Key Information:

Vendor

IBM
Status
Rational Quality Manager
Rational Team Concert
Engineering Workflow Management
Engineering Test Management
Vendor
CVE Published:
4 March 2021

What is CVE-2021-20350?

IBM Engineering products are exposed to a cross-site scripting vulnerability, enabling attackers to inject and execute arbitrary JavaScript code through the web user interface. This flaw allows for manipulation of the application's intended functionality, and could potentially lead to the exposure of user credentials during trusted sessions. It is crucial for users of IBM Engineering products to assess their systems and implement necessary security measures to mitigate this risk. For more information, visit IBM's official support page and X-Force ID database.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Engineering Lifecycle Optimization 7.0

Engineering Lifecycle Optimization 7.0.1

Engineering Lifecycle Optimization 7.0.2

References

https://www.ibm.com/support/pages/node/6417585
x_refsource_CONFIRM
https://exchange.xforce.ibmcloud.com/vulnerabilities/194707
vdb-entryx_refsource_XF

CVSS V3.1

Score:
5.4
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.